From a biochemical compounding perspective, this medication represents a unique case, primarily due to its mode of operation. The primary compound, naproxen, demonstrates a complex interplay with prostaglandin synthesis, specifically targeting cyclooxygenase-2 (COX-2) enzymes. This selective inhibition seeks to reduce inflammation and pain while… Read More